GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Dec 2025 01:50 PM
RNS
Nucala receives positive CHMP opinion for COPD
12 Dec 2025 01:41 PM
RNS
Depemokimab receives positive CHMP opinion
12 Dec 2025 07:00 AM
RNS
Positive CHMP opinion on Arexvy for all adults 18+
12 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
11 Dec 2025 05:54 PM
RNS
Blujepa approved in US for gonorrhoea indication
11 Dec 2025 03:30 PM
RNS
Director/PDMR Shareholding
11 Dec 2025 09:00 AM
RNS
Block Listing Application
11 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
10 Dec 2025 07:00 AM
RNS
GSK'227 US FDA Orphan Drug Designation in SCLC
10 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
09 Dec 2025 03:30 PM
RNS
Director/PDMR Shareholding
09 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
08 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
05 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
04 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
03 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
02 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
01 Dec 2025 03:30 PM
RNS
Director/PDMR Shareholding
01 Dec 2025 03:00 PM
RNS
Total Voting Rights
01 Dec 2025 07:00 AM
RNS
Transaction in Own Shares
28 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
27 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
26 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
25 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
24 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
21 Nov 2025 07:00 AM
RNS
Initiation of litigation against AnaptysBio Inc
21 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
20 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
19 Nov 2025 07:15 AM
RNS
Transfer of Treasury Shares
19 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
18 Nov 2025 03:30 PM
RNS
Director/PDMR Shareholding
18 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
17 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
14 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
13 Nov 2025 03:30 PM
RNS
Director/PDMR Shareholding
13 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
12 Nov 2025 03:30 PM
RNS
Block listing Interim Review
12 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
11 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
10 Nov 2025 03:00 PM
RNS
GSK publishes provisional dividend dates
10 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
07 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
06 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
05 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
04 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
03 Nov 2025 03:00 PM
RNS
Total Voting Rights
03 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
31 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
30 Oct 2025 03:30 PM
RNS
Director/PDMR Shareholding
30 Oct 2025 07:00 AM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings